Literature DB >> 20039378

Estimation of genotype relative risks from pedigree data by retrospective likelihoods.

Daniel J Schaid1, Shannon K McDonnell, Shaun M Riska, Erin E Carlson, Stephen N Thibodeau.   

Abstract

Pedigrees collected for linkage studies are a valuable resource that could be used to estimate genetic relative risks (RRs) for genetic variants recently discovered in case-control genome wide association studies. To estimate RRs from highly ascertained pedigrees, a pedigree "retrospective likelihood" can be used, which adjusts for ascertainment by conditioning on the phenotypes of pedigree members. We explore a variety of approaches to compute the retrospective likelihood, and illustrate a Newton-Raphson method that is computationally efficient particularly for single nucleotide polymorphisms (SNPs) modeled as log-additive effect of alleles on the RR. We also illustrate, by simulations, that a naïve "composite likelihood" method that can lead to biased RR estimates, mainly by not conditioning on the ascertainment process-or as we propose-the disease status of all pedigree members. Applications of the retrospective likelihood to pedigrees collected for a prostate cancer linkage study and recently reported risk-SNPs illustrate the utility of our methods, with results showing that the RRs estimated from the highly ascertained pedigrees are consistent with odds ratios estimated in case-control studies. We also evaluate the potential impact of residual correlations of disease risk among family members due to shared unmeasured risk factors (genetic or environmental) by allowing for a random baseline risk parameter. When modeling only the affected family members in our data, there was little evidence for heterogeneity in baseline risks across families. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20039378      PMCID: PMC2860197          DOI: 10.1002/gepi.20460

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  33 in total

1.  A marginal likelihood approach for estimating penetrance from kin-cohort designs.

Authors:  N Chatterjee; S Wacholder
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  Bias and efficiency in family-based gene-characterization studies: conditional, prospective, retrospective, and joint likelihoods.

Authors:  P Kraft; D C Thomas
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

3.  Pseudo-likelihood estimates of the cumulative risk of an autosomal dominant disease from a kin-cohort study.

Authors:  D F Moore; N Chatterjee; D Pee; M H Gail
Journal:  Genet Epidemiol       Date:  2001-02       Impact factor: 2.135

4.  Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.

Authors:  N Chatterjee; J Shih; P Hartge; L Brody; M Tucker; S Wacholder
Journal:  Genet Epidemiol       Date:  2001-09       Impact factor: 2.135

5.  Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.

Authors:  Hanne Meijers-Heijboer; Ans van den Ouweland; Jan Klijn; Marijke Wasielewski; Anja de Snoo; Rogier Oldenburg; Antoinette Hollestelle; Mark Houben; Ellen Crepin; Monique van Veghel-Plandsoen; Fons Elstrodt; Cornelia van Duijn; Carina Bartels; Carel Meijers; Mieke Schutte; Lesley McGuffog; Deborah Thompson; Douglas Easton; Nayanta Sodha; Sheila Seal; Rita Barfoot; Jon Mangion; Jenny Chang-Claude; Diana Eccles; Rosalind Eeles; D Gareth Evans; Richard Houlston; Victoria Murday; Steven Narod; Tamara Peretz; Julian Peto; Catherine Phelan; Hong Xiang Zhang; Csilla Szabo; Peter Devilee; David Goldgar; P Andrew Futreal; Katherine L Nathanson; Barbara Weber; Nazneen Rahman; Michael R Stratton
Journal:  Nat Genet       Date:  2002-04-22       Impact factor: 38.330

Review 6.  Searching for genetic determinants in the new millennium.

Authors:  N J Risch
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

7.  Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.

Authors:  Alice J Sigurdson; Michael Hauptmann; Nilanjan Chatterjee; Bruce H Alexander; Michele Morin Doody; Joni L Rutter; Jeffery P Struewing
Journal:  BMC Cancer       Date:  2004-03-12       Impact factor: 4.430

8.  Adjustment for competing risk in kin-cohort estimation.

Authors:  Nilanjan Chatterjee; Patricia Hartge; Sholom Wacholder
Journal:  Genet Epidemiol       Date:  2003-12       Impact factor: 2.135

9.  Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.

Authors:  Yuanjia Wang; Lorraine N Clark; Elan D Louis; Helen Mejia-Santana; Juliette Harris; Lucien J Cote; Cheryl Waters; Howard Andrews; Blair Ford; Steven Frucht; Stanley Fahn; Ruth Ottman; Daniel Rabinowitz; Karen Marder
Journal:  Arch Neurol       Date:  2008-04

10.  Kin-cohort evaluation of relative risks of genetic variants.

Authors:  Catherine L Saunders; Colin B Begg
Journal:  Genet Epidemiol       Date:  2003-04       Impact factor: 2.135

View more
  7 in total

1.  Multiple genetic variant association testing by collapsing and kernel methods with pedigree or population structured data.

Authors:  Daniel J Schaid; Shannon K McDonnell; Jason P Sinnwell; Stephen N Thibodeau
Journal:  Genet Epidemiol       Date:  2013-05-05       Impact factor: 2.135

2.  Efficient generalized least squares method for mixed population and family-based samples in genome-wide association studies.

Authors:  Jia Li; James Yang; Albert M Levin; Courtney G Montgomery; Indrani Datta; Sheri Trudeau; Indra Adrianto; Paul McKeigue; Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Genet Epidemiol       Date:  2014-05-20       Impact factor: 2.135

3.  Disease-specific prospective family study cohorts enriched for familial risk.

Authors:  John L Hopper
Journal:  Epidemiol Perspect Innov       Date:  2011-02-27

4.  An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.

Authors:  Melissa S DeRycke; Melissa C Larson; Asha A Nair; Shannon K McDonnell; Amy J French; Lori S Tillmans; Shaun M Riska; Saurabh Baheti; Zachary C Fogarty; Nicholas B Larson; Daniel R O'Brien; John C Cheville; Liang Wang; Daniel J Schaid; Stephen N Thibodeau
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

5.  A microRNA Transcriptome-wide Association Study of Prostate Cancer Risk.

Authors:  Nicholas B Larson; Shannon K McDonnell; Zachary Fogarty; Yuanhang Liu; Amy J French; Lori S Tillmans; John C Cheville; Liang Wang; Daniel J Schaid; Stephen N Thibodeau
Journal:  Front Genet       Date:  2022-03-30       Impact factor: 4.599

6.  Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer.

Authors:  D R Barnes; D Barrowdale; J Beesley; X Chen; P A James; J L Hopper; D Goldgar; G Chenevix-Trench; A C Antoniou; G Mitchell
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

7.  Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci.

Authors:  Nicholas B Larson; Shannon K McDonnell; Zach Fogarty; Melissa C Larson; John Cheville; Shaun Riska; Saurabh Baheti; Alexandra M Weber; Asha A Nair; Liang Wang; Daniel O'Brien; Jaime Davila; Daniel J Schaid; Stephen N Thibodeau
Journal:  Oncotarget       Date:  2017-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.